SightfileU.S. market data from official filings

Companies › RYTM

RHYTHM PHARMACEUTICALS INC COM (RYTM)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001649904 · EDGAR filings · Updated 2026-07-02

RHYTHM PHARMACEUTICALS INC COM (RYTM) has reported institutional ownership of 107.4%, with 285 institutional managers holding positions valued at $6.42B per the latest 13F reporting period.

Institutional ownership
107.4%
Institutional managers
285
Reported 13F value
$6.42B
Insider activity
134 trans.
−$32.3M net selling

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, RHYTHM PHARMACEUTICALS INC COM has 285 institutional holders and institutional ownership of 107.4%.

Insider activity

Insiders reported 134 transactions (0 buys, 68 sells) across 15 reporting insiders, with a net reported value of −$32.3M.

Related companies

APOGEE THERAPEUTICS INC (APGE) · SCHOLAR ROCK HLDG CORP (SRRK) · PTC THERAPEUTICS INC (PTCT) · AXSOME THERAPEUTICS INC. (AXSM) · MIRUM PHARMACEUTICALS INC (MIRM) · GLAUKOS CORP (GKOS)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-02.